These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8399577)
1. Blood glucose and cholesterol control improved by continuous ambulatory peritoneal dialysis in patients with end-stage renal disease and diabetes mellitus. Wikdahl AM; Granbom L; Sörensen JG; Stegmayr BG Perit Dial Int; 1993; 13 Suppl 2():S239-41. PubMed ID: 8399577 [TBL] [Abstract][Full Text] [Related]
2. Improvement of glycemic control by CAPD with intraperitoneal insulin in a child with IDDM and ESRD. Flynn JT; Kershaw DB; Sedman AB; Smoyer WE; Bunchman TE Adv Perit Dial; 1998; 14():265-8. PubMed ID: 10649738 [TBL] [Abstract][Full Text] [Related]
3. Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis. Wu MS; Yu CC; Wu CH; Haung JY; Leu ML; Huang CC Perit Dial Int; 1999; 19 Suppl 2():S179-83. PubMed ID: 10406515 [TBL] [Abstract][Full Text] [Related]
4. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin. Madden MA; Zimmerman SW; Simpson DP Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585 [TBL] [Abstract][Full Text] [Related]
5. Ultrasonic gallbladder function in chronic kidney disease: does predialysis, hemodialysis, or CAPD affect it? Bektas A; Belet U; Kelkitli E; Bakir T; Acikgoz A; Akpolat T Ren Fail; 2005; 27(6):677-81. PubMed ID: 16350817 [TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical characteristics of type 2 diabetic patients on continuous ambulatory peritoneal dialysis: relationships with insulin requirement. Wong TY; Chan JC; Szeto CC; Leung CB; Li PK Am J Kidney Dis; 1999 Sep; 34(3):514-20. PubMed ID: 10469863 [TBL] [Abstract][Full Text] [Related]
7. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD. Nevalainen PI; Lahtela JT; Mustonen J; Taskinen MR; Pasternack A Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186 [TBL] [Abstract][Full Text] [Related]
8. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes. Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573 [TBL] [Abstract][Full Text] [Related]
9. Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis. Yu CC; Wu MS; Wu CH; Yang CW; Huang JY; Hong JJ; Fan Chiang CY; Leu ML; Huang CC Perit Dial Int; 1997; 17(3):262-8. PubMed ID: 9237287 [TBL] [Abstract][Full Text] [Related]
10. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy. Grefberg N; Danielson BG; Nilsson P Acta Med Scand; 1984; 215(5):427-34. PubMed ID: 6377827 [TBL] [Abstract][Full Text] [Related]
11. [Program of continuous ambulatory peritoneal dialysis and renal transplantation in insulin-dependent diabetics in the terminal stage of renal insufficiency]. Mousson C; Tanter Y; Chalopin JM; Rifle G Nephrologie; 1987; 8(4):205-9. PubMed ID: 3320798 [TBL] [Abstract][Full Text] [Related]
12. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients. Nevalainen P; Lahtela JT; Mustonen J; Pasternack A Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790 [TBL] [Abstract][Full Text] [Related]
13. Establishing HbA1c -mean blood glucose formulae for patients on continuous ambulatory peritoneal dialysis. Zhao C; Luo Q; He F; Peng F; Xia X; Huang F; Yu X Diabet Med; 2014 Jul; 31(7):813-20. PubMed ID: 24628621 [TBL] [Abstract][Full Text] [Related]